COVID-19 – Critical Care Medicines Demand/Supply Management

Posted on:

In order to manage additional demand for medicines in critical care and anaesthesia during the on-going COVID-19 pandemic, the Royal College of Anaesthetists, Association of Anaesthetists, Faculty of Intensive Care Medicine, Intensive Care Society and UK Clinical Pharmacy Association have worked closely with the Chief Pharmaceutical Officer at NHS England to publish the following Drug demand-supply clinical guidance and patient-focussed FAQs: